CIBC Bancorp USA’s Cogent Biosciences COGT Stock Holding History

CIBC Bancorp USA’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$356K	Buy	9,208 +2,009	+28%	+$70.3K	﹤0.01%	1453
2026 Q1	$277K	Buy	+7,199	New	+$266K	﹤0.01%	1459
2025 Q3	$199K	Buy	+13,857	New	+$164K	﹤0.01%	1264

Other funds holding COGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

CIBC Bancorp USA's COGT Position: Q2 2026 in Review

CIBC Bancorp USA increased its Cogent Biosciences (COGT) stake by 28% in Q2 2026, buying an estimated $70.3K and bringing the position to 9,208 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #1453.

CIBC Bancorp USA first reported a position in COGT in Q3 2025 and has held it in 3 quarters since. 290 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

CIBC Bancorp USA held 9,208 shares of Cogent Biosciences worth $356K as of Q2 2026.
CIBC Bancorp USA bought 2,009 Cogent Biosciences shares in Q2 2026, an estimated $70.3K.
Cogent Biosciences made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1453 holding.
CIBC Bancorp USA first reported a position in Cogent Biosciences in Q3 2025 and has held it in 3 quarters since.
290 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.